SEC Form 6-K Summary
Registrant: Flora Growth Corp. The request metadata identifies “Zerostack Corp.,” but the filing identifies Flora Growth Corp. as the registrant.
Reporting period: February 2022; filed February 28, 2022. The material event occurred on February 24, 2022.
Business Context and Transaction
Flora Growth U.S. Holdings Corp., a wholly owned subsidiary of Flora Growth Corp., completed the acquisition of 100% of the equity interests in Just Brands LLC and High Roller Private Label LLC.
The acquisition was completed under a securities purchase agreement dated February 24, 2022. The filing provides transaction terms but does not provide historical financial statements or operating results for the acquired companies.
Purchase Consideration and Key Terms
- Cash consideration: $16.0 million.
- Share consideration: 9.5 million privately issued Flora common shares.
- Cash escrow: $1.0 million was placed in escrow for potential working-capital purchase-price adjustments.
- Share escrow: 3,166,667 shares were placed in escrow for potential 2021 revenue and EBITDA shortfalls, indemnification claims, and certain pre-closing litigation-related costs.
- Performance and price protection: During the 24-month reference period, additional shares may be issued if Flora’s five-day VWAP does not meet the contractual share price or if specified escrow-share sale conditions occur.
- Maximum additional shares: Flora is not required to issue more than 3.65 million additional shares without shareholder approval. If approval is not obtained and additional shares above that threshold are required, cash may be delivered instead.
- Lock-up: Sellers agreed not to sell the Flora shares for six months after closing.
- Restrictive covenants: Sellers agreed not to compete with the acquired businesses or solicit their employees for two years after closing.
- Resale registration: Flora agreed to use commercially reasonable efforts to register the share consideration for resale on Form F-3 or Form S-3, or on Form F-1 or Form S-1 if required.
Financial Metrics, Liquidity, and Debt
The filing does not provide revenue, profit, cash flow, margins, debt, cash balances, liquidity measures, or pro forma financial information for Flora or the acquired companies. The transaction requires $16.0 million of cash consideration, including $1.0 million placed in escrow, but the filing does not state the source of funding or the effect on liquidity.
Material Changes Versus the Prior Comparable Period
No comparable-period operating results are presented. The primary reported change is the completion of the acquisition and the resulting potential dilution from 9.5 million issued shares, 3,166,667 escrow shares, and possible additional shares.
Outlook, Risks, and Unusual Items
- Potential future dilution or cash obligations depend on the acquired companies’ audited 2021 revenue and EBITDA, working capital, indemnification claims, litigation matters, Flora’s share price, and the contractual VWAP formula.
- Additional shares could be issued during or after the 24-month reference period, subject to the 3.65 million shareholder-approval limitation and possible cash settlement for excess shares.
- The $1.0 million cash escrow may be reduced if delivered working capital is below the agreed target.
- Escrowed shares may be used to satisfy performance shortfalls, indemnification claims, or pre-closing litigation-related costs.
- The filing cautions that representations and warranties in the purchase agreement were made for contractual risk allocation and should not be treated as independently verified descriptions of the parties or businesses.
Important Facts for Investors to Verify
- Review the full securities purchase agreement, including the share-price, VWAP, escrow, working-capital, and additional-share formulas.
- Verify the acquired companies’ audited 2021 revenue and EBITDA against the contractual targets.
- Assess the funding source for the $16.0 million cash payment and the effect on Flora’s liquidity.
- Monitor the 24-month reference period for potential additional shares or cash settlement obligations.
- Review subsequent filings for purchase-accounting treatment, acquired-company financial statements, goodwill or intangible assets, and pro forma results.
- Confirm the status and timing of resale registration for the issued and issuable shares.